LES Royalty Survey Studies have provided valuable insights into the dynamics of the licensing market, serving as invaluable references for licensing professionals. In 2024, LES USA and Canada conducted its Life Sciences Survey Study. Join us for an exclusive preview of the results. This session will cover (i) benchmark royalty payment data: including royalty rates, upfront payments, and milestone payments across major therapeutic areas; and (ii) survey process: detailing data collection and methodology. The goal of this session is to showcase the benchmark royalty data available exclusively to the LES community and to review key deal terms (e.g., structure of royalty payments: flat vs. tiered royalty rates; royalty rates by clinical trial phase; development and sales milestones vs. clinical trial phases; and payment structures).
